The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Senior US general warns of possible looming war with China

  • 3

    BLACKPINK sets 6 more Guinness records

  • 5

    Jang Keun-suk steps out of his comfort zone with 'The Bait'

  • 7

    ENA's new dating show to spotlight young adult's romance

  • 9

    Cabinet ministries turn deaf ear to watchdog's advice on sexual minorities

  • 11

    Seoul to work with Hanoi to pursue peace on Korean peninsula

  • 13

    Korea's rice consumption hits another low in 2022: data

  • 15

    To speak Korean

  • 17

    12 websites still unavailable after Chinese cyberattacks

  • 19

    Indonesia celebrates 50th anniversary of diplomatic ties with Korea via virtual event

  • 2

    People attempt to cut surging heating costs with creative solutions

  • 4

    National pension anticipated to be fully drained in 2055: NPS

  • 6

    TXT brings together 'pansori' and fairy tale in new song 'Sugar Rush Ride'

  • 8

    Bad weather disrupts operation of Jeju airport again after 3 days

  • 10

    More Korean manufacturers enjoy Georgia's hospitality

  • 12

    Superintendent of Seoul Education Office gets suspended jail term

  • 14

    Opposition leader Lee claims innocence in corruption probe

  • 16

    Police to build disaster prediction system to prevent recurrence of Itaewon tragedy

  • 18

    SK E&S retains gov't support for Barossa gas project in Australia

  • 20

    Cambodian ministers highlight potential for growth, cooperation

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
Sun, January 29, 2023 | 20:52
Economy
Hanmi under probe over insider trading
Posted : 2016-10-03 18:00
Updated : 2016-10-03 19:26
Nam Hyun-woo
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
Hanmi Pharmaceutical CEO Lee Gwan-sun speaks during a press conference on the company's disclosure delay and possible side effects of its lung cancer treatment Olmutinib at the company headquarters in Songpa-gu, southeastern Seoul, Sunday. / Yonhap
Hanmi Pharmaceutical CEO Lee Gwan-sun speaks during a press conference on the company's disclosure delay and possible side effects of its lung cancer treatment Olmutinib at the company headquarters in Songpa-gu, southeastern Seoul, Sunday. / Yonhap

By Nam Hyun-woo


The financial regulator will investigate Hanmi Pharmaceutical on suspicions of insider trading, after a belated posting rattled the Korean stock market last week.

The Financial Services Commission (FSC) and the Financial Supervisory Service (FSS) said Sunday that they will look into whether Hanmi posted a canceled deal properly and whether top managers have been engaged in any insider trading.

The Korea Exchange (KRX) will also investigate the latter.

The authorities will focus on the massive flow of Hanmi and its holding company Hanmi Science stocks, including possible short selling, to find out whether they reaped any illicit gains.

On Sept. 30, Hanmi shares closed at 508,000 won, down 18.06 percent. The plunge followed a bullish opening on the company's after-hour public notice a day earlier that the company inked a 1 trillion won deal with Genentech, a U.S. biotechnology firm, over targeted anticancer drug technology.

Thirty minutes after the market opening, however, Hanmi announced that Boehringer Ingelheim had cancelled a deal on the clinical development of the lung cancer treatment Olmutinib. Hanmi shares plunged on the news, losing 1.5 trillion won of market value at the end of the day's trading.

Investors dump Hanmi Pharm shares
2016-10-04 17:23  |  Economy
Drug developers caught in low success rate
Drug developers caught in low success rate
2016-10-03 14:15  |  Companies
Investors furious over Hanmi's report delay
2016-10-02 16:56  |  Companies
On Friday, 104,327 Hanmi shares were the target of short-selling, the biggest one-day volume since the company was listed in 2010. It is also more than the 20 times the Hanmi average of short-selling volume of 4,850 shares this year.

Short-selling refers to a trading strategy in which an investor sells borrowed stocks in anticipation of a price decline. After the decline, the investor can buy the stocks at a cheaper price and enjoy benefits from the margin.

Questions and criticisms are mounting on Hanmi, because the company could have posted the cancellation at an earlier time. In a press conference on Sunday, Hanmi Pharmaceutical CEO Lee Gwan-sun said that the company received notice of cancellation at 7:06 p.m. on Sept. 29.

Lee said it took time for the company to take appropriate procedures under KRX regulations, but suspicions are rising that the company had enough time to report the cancellation because it was aware of the progress of a rival drug Osimertinib by AstraZeneca and the side effects of Olmutinib, which Lee said were cited as reasons by Boehringer Ingelheim for the cancellation.

This is not the first time that Hanmi Pharmaceutical caused a stir.

On July 28 last year, Hanmi announced the deal with Boehringer Ingelheim and enjoyed a surge a day later. However, on the same day, the company announced its second quarter performance, which was far lower than expectations.

Hanmi Pharmaceutical's stock price once hit 606,000 won on the day, but ended at 445,000 won.

In a separate case, a Hanmi researcher was sentenced to a prison term for earning 87 million won unfairly through insider trading.

Meanwhile, the Ministry of Food and Drug Safety will announce on Tuesday whether it will order the suspension of domestic sales of Hanmi's Olita Tab, a component of Olmutinib.

Emailnamhw@ktimes.com Article ListMore articles by this reporter
 
wooribank
Top 10 Stories
1Cambodian ministers highlight potential for growth, cooperationCambodian ministers highlight potential for growth, cooperation
2Suicidal pedestrian saved over Han River bridge Suicidal pedestrian saved over Han River bridge
3Korea to lift indoor mask mandate MondayKorea to lift indoor mask mandate Monday
4[INTERVIEW] Busan has potential to be world-class city, says mayorINTERVIEWBusan has potential to be world-class city, says mayor
5Youth, foreign drug offenders increase threefold in 5 years Youth, foreign drug offenders increase threefold in 5 years
6Hana unveils vision to become Asia's best financial group Hana unveils vision to become Asia's best financial group
7Seoul International School celebrates 50th anniversary Seoul International School celebrates 50th anniversary
8Main opposition leader faces pressure to resign in case of indictment Main opposition leader faces pressure to resign in case of indictment
9Bank operating hours return to normal amid union opposition Bank operating hours return to normal amid union opposition
10Samsung to introduce low-carbon diet for employees to help tackle climate change Samsung to introduce low-carbon diet for employees to help tackle climate change
Top 5 Entertainment News
1BLACKPINK sets 6 more Guinness records BLACKPINK sets 6 more Guinness records
2Jang Keun-suk steps out of his comfort zone with 'The Bait' Jang Keun-suk steps out of his comfort zone with 'The Bait'
3TXT brings together 'pansori' and fairy tale in new song 'Sugar Rush Ride' TXT brings together 'pansori' and fairy tale in new song 'Sugar Rush Ride'
4ENA's new dating show to spotlight young adult's romance ENA's new dating show to spotlight young adult's romance
5Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity' Kim Jung-hyun returns to small screen with 'Kokdu: Season of Deity'
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

wooribank
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group